Heparin recall spreads in Europe

Mar 27, 2008

France, Italy and Denmark are recalling heparin after an Italian firm purchased contaminated ingredients from China, EU drug regulators said.

The drug has already been recalled in Germany and the United States.

The Wall Street Journal reported China's Shenzhen Hepalink Pharmaceutical Co., which supplies ingredients to U.S.-based APP Pharmaceuticals also supplied Italian company Opocrin. The Italian company said Tuesday it bought some ingredients from Shenzhen that turned out to be contaminated, the newspaper said.

APP said the Italian heparin ingredients were obtained through a different pig slaughterhouse and that APP heparin produced in the United States has consistently tested contaminant-free.

Copyright 2008 by United Press International

Explore further: Study: US parents increasingly ask doctors to delay vaccines

add to favorites email to friend print save as pdf

Related Stories

CT scan taken of mummified remains in statue

26 minutes ago

(Phys.org) —A CT scan and endoscopy have revealed a master's mummy inside a Buddha statue. These were mummified remains of an ancient Buddhist monk who lived during the 11th or 12th century. Investigations ...

Trial nears in high-profile Silicon Valley sex bias case

4 hours ago

(AP)—A jury was picked Monday to determine whether a venerable Silicon Valley venture capital firm is liable in a sexual discrimination lawsuit or is the victim of a former employee forced out because of ...

Recommended for you

Drug research and development more efficient than expected

Feb 27, 2015

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.